Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Real-World Outcomes of IDH Mutant AML Patients Treated with or without IDH Inhibitors

Ali Al Sbihi, Sushmitha Nanja Reddy, Vikram Dhillon, Enxhi Lalo, Harry Ramos, Abdul Moiz Khan, Suresh Kumar Balasubramanian

Blood (2022) 140 (Supplement 1): 6189–6190.

https://doi.org/10.1182/blood-2022-171131

Published: 2022

Journal Articles

Real-World Outcomes and Cardiac Implications of FLT3 Inhibitors in Acute Myeloid Leukemia

Vikram Dhillon, Abdul Moiz Khan, Ali Al Sbihi, Sushmitha Nanja Reddy, Enxhi Lalo, Harry Ramos, Jay Yang, Anupama Kottam, Suresh Kumar Balasubramanian

Blood (2022) 140 (Supplement 1): 6183–6184.

https://doi.org/10.1182/blood-2022-169932

Published: 2022

Journal Articles

Efficacy Analysis of Different FLT3 Inhibitors in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Patients - a Systematic Review and Meta-Analysis

Mahesh Swaminathan, Mai M M Aly, Katherine G. Akers, Seongho Kim, Harry Ramos, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2021) 138 (Supplement 1): 1225.

https://doi.org/10.1182/blood-2021-154098

Published: 2021

Journal Articles

A Systematic Review and Meta-Analysis Comparing Type I and II FLT3 Inhibitors in Relapsed/ Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Mai M M Aly, Mahesh Swaminathan, Katherine G. Akers, Seongho Kim, Harry Ramos, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2021) 138 (Supplement 1): 1249.

https://doi.org/10.1182/blood-2021-148902

Published: 2021